Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Retatrutide is investigational and not FDA-approved, so no licensed pharmacy or provider sells it as an authorized product
Currently, two FDA-approved GLP-1 receptor agonists are directly derived from the Gila monster venom peptide exendin-4: exenatide (Byetta) and exenatide extended-release (Bydureon, Bydureon BCise)
The Medicare GLP-1 Bridge allows only one 28- or 30-day supply per fill
When a plateau occurs, your clinician evaluates whether a dose increase is appropriate or whether metabolic rest, dietary refinement, or activity enhancement would serve you better
US$ 23.24
US$ 21.62
US$ 26.34
US$ 21.69
US$ 24.86
:max_bytes(150000):strip_icc()/VWH-GettyImages-2158519129-372ed708fbbb4c6e9f472a8218cd52ee.jpg)
US$ 25.18
US$ 20.61
